bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 17 citations · 106 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeuropharmacologyPsychopharmacologyNeurotransmissionSerotonergic PharmacologySerotonergic SignalingSynaptic TransmissionExcitatory Pyramidal NeuronsPrefrontal Cortex PhysiologyPrefrontal Thalamocortical CircuitsPyramidal Neuron PhysiologySerotonergic CircuitrySerotonergic ModulationSerotonergic Neuronal PathwaysSerotonin Receptors
Rs). Here, we instead find that multiple classes of psychedelics dose-dependently suppress intrinsic excitability of pyramidal neurons, and that extracellular delivery of psychedelics decreases excitability significantly more than intracellular delivery. A previously unknown mechanism underlies this psychedelic drug action: enhancement of ubiquitously expressed potassium "M-current" channels that is independent of 5-HT2R activation. Using machine-learning-based data assimilation models, we show that M-current activation interacts with previously described mechanisms to dramatically reduce intrinsic excitability and shorten working memory timespan. Thus, psychedelic drugs suppress intrinsic excitability by modulating ion channels that are expressed throughout the brain, potentially triggering homeostatic adjustments that can contribute to widespread therapeutic benefits.
106
Matplotlib: A 2D Graphics Environment
John D. Hunter · Computing in Science & Engineering · 2007 · 39.6K citations
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart‐Harris, Bruna Giribaldi, Rosalind Watts et al. · New England Journal of Medicine · 2021 · 1.4K citations
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Alan K. Davis, Frederick S. Barrett, Darrick G. May et al. · JAMA Psychiatry · 2020 · 1.3K citations · Full text